Immatics (IMTX) Assets Average (2020 - 2025)
Immatics' (IMTX) quarterly Assets Average came in at $630.4 million in Q4 2025, down 8.49% year-on-year from $688.9 million in Q4 2024, and up 1.0% quarter-over-quarter from $624.2 million in Q3 2025.
Immatics (IMTX) Assets Average (2020 - 2025) Analysis & Trends
Immatics has disclosed Assets Average across 6 years of filings, most recently posting $630.4 million for Q4 2025.
- Assets Average for Q4 2025 came in at $630.4 million, down 8.49% year-over-year; the trailing twelve-month figure through Dec 2025 was $630.4 million (down 8.49% YoY), and the FY2025 annual result was $689.6 million, up 6.7% from the prior year.
- Assets Average came in at $630.4 million for Q4 2025 at Immatics, up from $624.2 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $709.4 million in Q1 2025 to a low of $217.2 million in Q4 2021.
- The 5-year median for Assets Average is $443.9 million (2023), against an average of $475.4 million.
- Across the five-year window, Assets Average tumbled 31.51% in 2021 and soared 78.03% in 2022, its largest moves.
- Immatics' Assets Average stood at $217.2 million in 2021, then jumped by 78.03% to $386.7 million in 2022, then soared by 32.54% to $512.4 million in 2023, then jumped by 34.44% to $688.9 million in 2024, then slipped by 8.49% to $630.4 million in 2025.
- The last three Assets Average figures came in at $630.4 million (Q4 2025), $624.2 million (Q3 2025), and $658.6 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 33.42 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 795.91 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13.04 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.72 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 26.03 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 40.89 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 10.06 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 26.06 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 660.38 Mn |
| 10 | Immatics | 14.67 Bn | 14.67 Bn | - | 630.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 630.40 Mn |
| Sep 30, 2025 | 624.19 Mn |
| Jun 30, 2025 | 658.57 Mn |
| Mar 31, 2025 | 709.44 Mn |
| Dec 31, 2024 | 688.91 Mn |
| Sep 30, 2024 | 654.55 Mn |
| Jun 30, 2024 | 692.35 Mn |
| Mar 31, 2024 | 629.11 Mn |
| Dec 31, 2023 | 512.45 Mn |
| Sep 30, 2023 | 461.43 Mn |
| Jun 30, 2023 | 426.46 Mn |
| Mar 31, 2023 | 411.16 Mn |
| Dec 31, 2022 | 386.65 Mn |
| Sep 30, 2022 | 375.11 Mn |
| Jun 30, 2022 | 354.85 Mn |
| Mar 31, 2022 | 258.25 Mn |
| Dec 31, 2021 | 217.18 Mn |
| Sep 30, 2021 | 247.65 Mn |
| Jun 30, 2021 | 273.77 Mn |
| Mar 31, 2021 | 295.21 Mn |